Reducing mortality risk by targeting specific air pollution sources: Suva, Fiji
C F Isley1, P F Nelson1, M P Taylor1
1Department of Environmental Sciences, Macquarie University, Sydney, NSW 2109, Australia.
The Science of the Total Environment
|September 2, 2017
Summary
Reducing air pollution from fossil fuels, vehicles, and waste burning in Suva can significantly lower mortality rates. This study quantifies the health benefits of targeting specific pollution sources in the Pacific Island city.
Area of Science:
- Environmental Science
- Public Health
- Atmospheric Chemistry
Background:
- Health impacts of air pollution are source-dependent.
- Particulate matter (PM2.5) poses significant health risks.
- Understanding source-specific risks is crucial for effective mitigation.
Purpose of the Study:
- To determine the mortality reduction value of decreasing PM2.5 from various emission sources.
- To use Suva, a Pacific Island city, as a case study.
- To compare source-specific health risks of PM2.5.
Main Methods:
- Elemental concentration analysis of PM2.5 samples using ion beam analysis.
- Quantification of PM2.5 sources via positive matrix factorization.
- Literature review for mortality risk factors associated with emission sources.
Main Results:
- PM2.5 from fossil fuel combustion, vehicle emissions, and waste burning showed higher mortality risks than PM2.5 mass alone.
- Black carbon and sulfur content contributed to elevated risk ratios.
- Predicted mortality from fossil fuel smoke in Suva exceeded Fiji's road accident fatalities.
Conclusions:
- Reducing emissions from fossil fuel combustion (diesel), vehicles, and waste burning offers the greatest mortality reduction benefits for Suva.
- Source-specific PM2.5 risk assessment is vital for targeted public health interventions.
- Air quality management strategies should prioritize high-risk emission sources.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
750
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
750
Atherosclerosis III: Management
476
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
476
Factors Affecting Pulmonary Ventilation
3.4K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
3.4K
Asthma-IV: Nursing Management
3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.9K
COPD: Management Using Bronchodilators and Corticosteroids
907
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
907
Acute Respiratory Failure-V
541
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
541


